Pelotonia is a grassroots bike tour with one goal: to end cancer
Not Yet Registered?
If you have not yet registered to participate in Pelotonia 17, click here to register as a Rider, Virtual Rider, or Volunteer.
Close Tab

Pelotonia Receives Funding from Lilly for Innovative New Technology Project Designed to Raise Funds for Cancer Research

FOR IMMEDIATE RELEASE
Contact: Rae Bazzarre The MACH 1 Group for Pelotonia (202) 320-5134 rbazzarre@themach1group.com

Pelotonia Receives Funding from Lilly for Innovative New Technology Project Designed to Raise Funds for Cancer Research

COLUMBUS, OH (Feb. 22, 2017) – Pelotonia, a grassroots organization that raises money to fund cancer research through its annual bike ride, announced today that Eli Lilly and Company (NYSE: LLY) is providing the initial grant funding to launch an innovative new technology project. The project will help Pelotonia to exponentially grow its fundraising momentum and provide direct and streamlined cancer education content within an engaging and rewarding digital experience.

“The success of Pelotonia has been unprecedented and unparalleled,” said Doug Ulman, Pelotonia President and CEO. “In the past eight years, approximately $18 million in operational investments from high impact companies has generated more than $130 million in grassroots fundraising for groundbreaking cancer research. We are proud and grateful to have the support of Lilly in helping us boldly embark on this new global, scalable project. We believe this funding will help us create a global grassroots movement of advocates and will have a significant impact in educating a health-focused group of users who may not otherwise be exposed to cancer-related information.”

Registration for Pelotonia ’17, which takes place Aug. 4-6, is now open at www.pelotonia.org. Pelotonia ’17 will hold its opening ceremony on Fri., Aug. 4. On Sat., Aug. 5, more than 7,500 riders will embark on 1- and 2-day rides on routes ranging from 25-180 miles and on Sun., Aug. 6, riders from the 130- and 180-mile routes will return to Columbus.

Pelotonia donates 100 percent of every rider-raised dollar directly to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). These donations are used to support cancer research in several ways:

  • Idea Grants, which investigate new and innovative basic, clinical, translation and population-based science clinical trials;
  • Fellowships, which provide for undergraduate, graduate, medical and postdoctoral students to acquire state-of-the-art equipment and technologies;
  • Funding research of the best and brightest physician scientists who are coming to Columbus, Ohio to further their passion for treating patients and pursuing scientific solutions.

Since its inception, Pelotonia has funded and awarded 99 idea grants and 405 fellowships as well as support for 79 senior scientists.

About Pelotonia
Founded in 2008, Pelotonia was established with the objective to fund life-saving cancer research. As a centerpiece of its year-round fundraising efforts, Pelotonia hosts a three-day experience that includes a weekend of cycling, entertainment and volunteerism. In its eight years, Pelotonia has raised over $130 million for cancer research. Thanks to its generous funding partners, Huntington Bank, L Brands Foundation, Peggy and Richard Santulli, American Electric Power Foundation, Nationwide, Cardinal Health Foundation, and Harold C. Schott Foundation, Pelotonia is able to direct 100 percent of every dollar raised by its participants to cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. For more information, visit www.pelotonia.org.

About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 46 National Cancer Institute-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anti-cancer drugs. As the cancer program’s 308-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit cancer.osu.edu.

Bookmark and Share